旅行筛查文件，以实现新发传染病的“识别-隔离-告知”框架：细节决定成败。

Travel-screening documentation to enable the "Identify-Isolate-Inform" framework for emerging infectious diseases: It's all in the details.

机构信息

Infection Control Unit, Massachusetts General Hospital, Boston, Massachusetts.

Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.

出版信息

Infect Control Hosp Epidemiol. 2020 Dec;41(12):1449-1451. doi: 10.1017/ice.2020.338. Epub 2020 Aug 27.

DOI:10.1017/ice.2020.338

PMID:32847641

Abstract

The early phase of the coronavirus disease 2019 (COVID-19) pandemic and ongoing efforts for mitigation underscore the importance of universal travel and symptom screening. We analyzed adherence to documentation of travel and symptom screening through a travel navigator tool with clinical decision support to identify patients at risk for Middle East Respiratory Syndrome.

摘要

新型冠状病毒病 2019（COVID-19）大流行的早期阶段和正在进行的缓解工作强调了普遍旅行和症状筛查的重要性。我们通过具有临床决策支持的旅行导航器工具分析了对旅行和症状筛查记录的依从性，以识别出患有中东呼吸综合征风险的患者。